OCI N.V. (Euronext: OCI), BioMCN’s parent company, announced an estimated €100 million investment to refurbish the second methanol production line at BioMCN, located at Chemical Park Delfzijl.
The production facility is currently mothballed, but prospects for methanol markets are attractive and the restart will create approximately 30 new permanent jobs at the site, in addition to several hundred indirect jobs during the refurbishment.
The production line can produce 438,000 tons of methanol per year and will almost double BioMCN’s current production capacity. The plant is expected to start commissioning in the fourth quarter of 2018.
The BioMCN plant in Delfzijl doubles its capacity
Versalis to acquire remaining 60% stake in Finproject to become the Italian leader in the production of special polymers
Closing is expected in the fourth quarter of 2021 and follows Versalis’ acquisition of 40% of the company which took place in July 2020. The operation will allow for the development of more special...
Lonza Invests to Expand Drug Product Development and Manufacturing Services in Switzerland
The expansion adds new capabilities to support clinical and commercial manufacturing and enhances existing drug product service offering in Basel and Visp (CH)
CF Industries Holdings, Inc. Commences Restart of Ammonia Plant at Billingham, UK, Complex
The restart follows an interim agreement reached today to cover the costs to restart the ammonia plant and produce CO2 for the UK market.
Versalis to acquire technologies and plants for the new mechanical recycling hub at Porto Marghera, Italy
Versalis accelerates developments in advanced mechanical recycling and expand the portfolio of the Versalis Revive® range of recycled polymers, consolidating its European leadership in recycled sty...